Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 1/2009

01.01.2009 | Original Article

Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer

verfasst von: Luiz Carlos Conti-Freitas, Maria Cristina Foss-Freitas, Rui Celso Martins Mamede, Norma Tiraboschi Foss

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Evaluate the production of TNF and IL-6 in the supernatant of peripheral blood mononuclear cell (PBMC) cultures of patients with supraglottic laryngeal cancer before and after surgical treatment.

Materials and methods

Adherent cell cultures were stimulated with LPS and BCG. Fourteen patients with advanced supraglottic laryngeal cancer were studied. Cytokine concentration was determined by ELISA in supernatants of mononuclear cell cultures.

Results

In non-stimulated cultures, lower TNF cytokine levels were detected during the late postoperative (LP) period compared to control (P = 0.02). LP TNF and IL-6 levels were high in cultures stimulated with LPS compared with the preoperative period (PREOP) (P = 0.007; P = 0.008, respectively). Stimulation with BCG led to increased levels of TNF and IL-6 during the LP period compared to control (P = 0.001; P = 0.04, respectively).

Conclusion

BCG is able to modulate the immune response of patients with advanced supraglottic laryngeal cancer in vitro, increasing the secretion of TNF and IL-6 by macrophages during the postoperative period.
Literatur
1.
Zurück zum Zitat Ballou SP, Lozanski G (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4:361–368PubMedCrossRef Ballou SP, Lozanski G (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4:361–368PubMedCrossRef
2.
Zurück zum Zitat Bemelmans MHA, Van Tits LJH, Buurman WA (1996) Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 16:1–11PubMed Bemelmans MHA, Van Tits LJH, Buurman WA (1996) Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 16:1–11PubMed
3.
Zurück zum Zitat Carswell EA, Old LJ, Kassel RL, Green S, Fiori N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666PubMedCrossRef Carswell EA, Old LJ, Kassel RL, Green S, Fiori N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666PubMedCrossRef
4.
Zurück zum Zitat Chretien PB (1975) Unique immunobiological aspects of head and neck squamous carcinoma. Can J Otolaryngol 4:222–235 Chretien PB (1975) Unique immunobiological aspects of head and neck squamous carcinoma. Can J Otolaryngol 4:222–235
5.
Zurück zum Zitat Conti-Freitas LC, Foss-Freitas MC, Mamede RCM, Foss NT (2007) Effect of surgical treatment on lymphoproliferation in advanced supraglottic aryngeal cancer. Laryngoscope 117(2):268–272PubMedCrossRef Conti-Freitas LC, Foss-Freitas MC, Mamede RCM, Foss NT (2007) Effect of surgical treatment on lymphoproliferation in advanced supraglottic aryngeal cancer. Laryngoscope 117(2):268–272PubMedCrossRef
6.
Zurück zum Zitat Coulie PG (1997) Human tumors are recognized by T cells: new perspectives for anti-cancer vaccines? Mol Med Today 3:261–268PubMedCrossRef Coulie PG (1997) Human tumors are recognized by T cells: new perspectives for anti-cancer vaccines? Mol Med Today 3:261–268PubMedCrossRef
7.
Zurück zum Zitat Dietz A, Heimlich F, Daniel V, Polarz H, Weidauer H, Maier H (2000) Immunomodulating effects of surgical intervention in tumors of head and neck. Otolaryngol Head Neck Surg 123(1):132–139PubMedCrossRef Dietz A, Heimlich F, Daniel V, Polarz H, Weidauer H, Maier H (2000) Immunomodulating effects of surgical intervention in tumors of head and neck. Otolaryngol Head Neck Surg 123(1):132–139PubMedCrossRef
8.
Zurück zum Zitat Donaldson RC (1972) Methotrexate plus bacillus calmette-guerin (BCG) and isoniazid in treatment of cancer of head and neck. Am J Surg 124:527–532PubMedCrossRef Donaldson RC (1972) Methotrexate plus bacillus calmette-guerin (BCG) and isoniazid in treatment of cancer of head and neck. Am J Surg 124:527–532PubMedCrossRef
9.
Zurück zum Zitat Foss MC, Foss NT, Paccola GMGF, Silva CL (1992) Serum levels of tumor necrosis factor in insulin-dependent diabetic patients. Braz J Med Biol Res 25:239–242PubMed Foss MC, Foss NT, Paccola GMGF, Silva CL (1992) Serum levels of tumor necrosis factor in insulin-dependent diabetic patients. Braz J Med Biol Res 25:239–242PubMed
10.
Zurück zum Zitat Gabay C, Krushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 11:448–454CrossRef Gabay C, Krushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 11:448–454CrossRef
11.
Zurück zum Zitat Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, Bondi R (1991) Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 117:1007–1010PubMed Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, Bondi R (1991) Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 117:1007–1010PubMed
12.
Zurück zum Zitat Gauldie J, Richards C, Lansdoro P, Baumann H (1987) Interferon-β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251–7255PubMedCrossRef Gauldie J, Richards C, Lansdoro P, Baumann H (1987) Interferon-β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251–7255PubMedCrossRef
13.
Zurück zum Zitat Katz AE (1983) Immunobiologic staging of patients with carcinoma of head and neck. Laryngoscope 93:445–463PubMed Katz AE (1983) Immunobiologic staging of patients with carcinoma of head and neck. Laryngoscope 93:445–463PubMed
14.
Zurück zum Zitat Kursrock R (2001) Cytokine deregulation on cancer. Biomed Pharmacother 55:543–547CrossRef Kursrock R (2001) Cytokine deregulation on cancer. Biomed Pharmacother 55:543–547CrossRef
15.
Zurück zum Zitat Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181–273PubMedCrossRef Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181–273PubMedCrossRef
16.
Zurück zum Zitat Marrack FM, Mitchell T, Hilceman D, Kedl R, Teague K, Kappler J (1998) T-cell survival. Immunol Rev 165:279–85PubMedCrossRef Marrack FM, Mitchell T, Hilceman D, Kedl R, Teague K, Kappler J (1998) T-cell survival. Immunol Rev 165:279–85PubMedCrossRef
17.
Zurück zum Zitat Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 137:2348–2357 Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 137:2348–2357
18.
Zurück zum Zitat Razack AH (2007) Bacillus Calmette-Guerin and bladder cancer. Asian J Surg 30(4):302–309PubMed Razack AH (2007) Bacillus Calmette-Guerin and bladder cancer. Asian J Surg 30(4):302–309PubMed
19.
Zurück zum Zitat Schantz SP, Liu FJ (1989) An immunologic profile of young adults with head and neck cancer. Cancer 64:1232–1237PubMedCrossRef Schantz SP, Liu FJ (1989) An immunologic profile of young adults with head and neck cancer. Cancer 64:1232–1237PubMedCrossRef
20.
Zurück zum Zitat Scully C (1982) The immunology of cancer of head and neck with particular reference to oral cancer. Oral Surg 53:157–169PubMedCrossRef Scully C (1982) The immunology of cancer of head and neck with particular reference to oral cancer. Oral Surg 53:157–169PubMedCrossRef
21.
Zurück zum Zitat Teague TK, Marrack P, Kappler JW, Vella AT (1997) IL-6 rescues resting mouse T cells from apoptosis. J Immunol 158:5791–5796PubMed Teague TK, Marrack P, Kappler JW, Vella AT (1997) IL-6 rescues resting mouse T cells from apoptosis. J Immunol 158:5791–5796PubMed
22.
Zurück zum Zitat Volanakis JE (1997) Acute phase proteins in rheumatic disease. In: Koopman W (ed) Arthritis and allied conditions: a textbook of rheumatology, 13th edn. Willians & Wilkins, Baltimore, pp 505–514 Volanakis JE (1997) Acute phase proteins in rheumatic disease. In: Koopman W (ed) Arthritis and allied conditions: a textbook of rheumatology, 13th edn. Willians & Wilkins, Baltimore, pp 505–514
23.
Zurück zum Zitat Wilson AG, Giovine FS, Duff GD (1995) Genetics of tumor necrosis factor-α in autoimmune, infection, and neoplastic diseases. J Inflamm 45:1–12PubMed Wilson AG, Giovine FS, Duff GD (1995) Genetics of tumor necrosis factor-α in autoimmune, infection, and neoplastic diseases. J Inflamm 45:1–12PubMed
Metadaten
Titel
Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer
verfasst von
Luiz Carlos Conti-Freitas
Maria Cristina Foss-Freitas
Rui Celso Martins Mamede
Norma Tiraboschi Foss
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 1/2009
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-008-0520-7

Weitere Artikel der Ausgabe 1/2009

Cancer Immunology, Immunotherapy 1/2009 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.